The Role of Aromatase Inhibitors in Male Prolactinoma.

Published in: Journal of clinical medicine (2023)

aromatase inhibitors are of potential value to patients with dopamine-agonist-resistant prolactinoma, or when hypogonadism persists while using high-dose dopamine agonists.

Keyphrases

high dose
uric acid
low dose
stem cell transplantation
prefrontal cortex
replacement therapy
metabolic syndrome
climate change